For those in the healthcare industry, telemedicine has been viewed as a way to increase access to healthcare, while mitigating the challenges of limited resources of physicians and healthcare providers. Although the use of telehealth has steadily grown over the past two decades, the challenges presented by the COVID-19 pandemic supercharged this growth. As the United States and the world move beyond the worst months and years of the pandemic, telemedicine usage will continue to change within the industry. This article from VMG Health explores the state of telehealth immediately prior to and during the early years of the pandemic to provide context for the question, “What will be the next stage of telemedicine in the U.S. healthcare system?” Read more.
Related Posts
Hospitals Turned to M&A to Shore up Core Operations in ’21
It was a year marked by a significant drop in transactions across the sector overall, but a higher percentage of larger-sized deals.
January 11, 2022
Bass, Berry & Sims: Healthcare Transactions Q1
2022 turned out to be a record year in the healthcare M&A market, so it was inevitable that 2023 began more slowly, especially given the many persistent headwinds.
April 18, 2023
End of the Line for FemTec Health
Founded in 2020, FemTec officially launched in October 2021 with more than $38 million in equity funding.
May 23, 2023
Investing in the New Era of Value-Based Care
Value-based care has evolved into a healthcare landscape of its own, with a wide range of organizations contributing to systematic changes that improve quality of care and outcomes while better controlling costs.
December 20, 2022